To be eligible, the majority of the business of the company, and its subsidiaries, must be in the healthcare (animal and human), medical, pharmaceutical, biotechnology or life sciences sectors. In addition, a significant part of the company's, and its subsidiaries', activities should involve scientific research and development which may or may not be product specific. These awards are open to quoted mediscience companies on recognised exchanges throughout Europe. For the Emerging Star category, this award was designed for private mediscience companies, although recently quoted public companies could also be considered, at the discretion of the Voting Panel.
A full list of companies eligible for the awards can be downloaded here.